Apomorphine Ampules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Apomorphine Ampules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Ampules-Insulin degludec
- Apomorphine Ampules-Insulin Degludec (U-100) Prefilled Pens
- Apomorphine Ampules-Insulin Degludec (U-100) Vials
- Apomorphine Ampules-Insulin Degludec (U-200) Prefilled Pens
- Apomorphine Ampules-Insulin degludec and liraglutide
- Apomorphine Ampules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Apomorphine Cartridges and Pens
- Insulin aspart, recombinant Subcutaneous-Apomorphine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Apomorphine Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Apra
- Insulin aspart, recombinant Subcutaneous-Apraclonidine
- Insulin aspart, recombinant Subcutaneous-Apraclonidine Hydrochloride